Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...

How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...

Prostate cancer remains one of the most common cancers among men, yet diagnosing it accurately has long been a challenge. The widely used PSA blood test often leads to confusion, as it can flag benign ...

May 28—Prostate cancer strikes one in nine men in Missouri, and thankfully there's a way to catch it early. May is Men's Health Month, and Dr. Mike Aberger of Phoenix Urology says blood tests for ...

For decades, the story of prostate cancer screening has been dominated by three letters: P-S-A. The Prostate-Specific Antigen blood test is the first line of defense for millions of men. Yet, for all ...

The LynxDx leadership team. In the front row (from left to right) are: Spencer Heaton, Chief Medical and Commercial Officer; Steve Riggs, President; and Jeff Crays, Chief Technology Officer. In the ...

New technologies and treatment methods are expanding men’s options. Here’s what you should know about your choices for ...

(CNN) — Editor’s note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and past president of the Florida Urological Society. Prostate cancer remains a significant concern ...

SAN DIEGO -- An algorithm-based decision tool eliminated inappropriate prescribing of bone-modifying agents (BMA) in patients with advanced prostate cancer, according to a VA-based study. Prior to ...